Urinary Dickkopf-3: a new biomarker for CKD progression and mortality.

Beatriz Sánchez-ÁlamoFrancisco José García-IñigoAmir ShabakaJuan Manuel AcedoClara Cases-CoronaPatricia Domínguez-TorresYunayka Diaz-EnamoradoEugenia LandaluceJuan F Navarro-GonzálezJose Luis Gorriz TeruelAlberto Martínez-CastelaoGema Fernández-Juárez

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)

uDKK3 identifies patients at high risk of CKD progression regardless of the cause of kidney injury. uDKK3 might serve as a useful biomarker for kidney disease progression and therefore could be used by clinicians to optimize staging for renal progression and monitor the response to potential treatments.

Keyphrases

chronic kidney disease
type diabetes
gene expression
risk assessment
pet ct
dna methylation
coronary artery disease